Ann: $29.6m Equity Placement to Lepu Medical Group of China, page-71

Thanks very much for your input to assist navigation of the Viralytics page.. found it, read it. Found this part very interesting

Viralytics is actively pursuing the most value-accretive pathways

When talking about licensing, or M & A or going it alone..

Sometimes it’s easy to imagine these guys in a lab, working hard at it and forgetting the rest of the ‘business’ side of things.. so it’s good that they are actively pursuing the most value-accretive pathways..

With a heap of $$ in the bank right now, any one of those pathways is a possibility right now..